Nextbio Holdings Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
28,925
20,513
18,839
17,854
7,156
Cost of Goods Sold (COGS) incl. D&A
28,691
21,428
24,619
15,717
4,979
Gross Income
233
915
5,780
2,137
2,177
SG&A Expense
4,636
3,654
3,269
4,801
2,782
EBIT
4,488
4,628
9,086
2,706
652
Unusual Expense
5,098
3,311
11,203
681
3
Non Operating Income/Expense
560
238
586
605
1,165
Interest Expense
466
274
509
1,107
308
Pretax Income
9,317
7,872
20,143
3,700
329
Income Tax
766
1,612
1,594
-
-
Consolidated Net Income
10,083
9,484
21,737
3,700
329
Net Income
9,645
8,394
20,512
3,563
329
Net Income After Extraordinaries
12,709
8,394
20,512
3,563
329
Net Income Available to Common
9,645
8,394
20,512
3,563
329
EPS (Basic)
373.00
466.00
1,159.00
198.00
17.00
Basic Shares Outstanding
18
18
18
18
19
EPS (Diluted)
373.11
466.18
1,143.66
197.74
17.20
Diluted Shares Outstanding
18
18
18
18
19
EBITDA
2,836
3,308
7,785
2,101
353
Other Operating Expense
86
59
37
41
47
Non-Operating Interest Income
175
103
68
189
120
Minority Interest Expense
438
1,090
1,225
137
-
About Nextbio Holdings Co.
View Profile
